comparemela.com

அலன் சஹேல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How Optogenetics Can Help Unlock Vision Loss Treatment

How Optogenetics Can Help Unlock Vision Loss Treatment
neurologyadvisor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neurologyadvisor.com Daily Mail and Mail on Sunday newspapers.

GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ

GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®

GenSight Biologics to Host Key Opinion Leader Webcasts on the Topline Results from REFLECT Phase III Clinical Trial of LUMEVOQ®
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Blind man regains partial vision after optogenetic therapy

Blind man regains partial vision after optogenetic therapy A new type of gene therapy has helped a man regain some vision after 40 years. The French man, who was diagnosed with retinitis pigmentosa (RP) in his teens, began to show signs of visual improvement a few months after the therapy, and was able to see things like the stripes of a pedestrian crossing, and objects on a table in from of him.  The findings provide proof of concept that using optogenetic therapy to partially restore vision is possible, said co-author Professor Botond Roska, from the Institute of Molecular and Clinical Ophthalmology in Basel, Switzerland.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.